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Tcchniqucs for plant transformation have been dcvclopcd to such an extent hat a number of foreign genes arc currently being introduced into 
transgcnic plants. Tobacco plants that produce monoclonal antibodies arc of intcresl, bccausc in addition to synthesis of two gcnc producls (i.e. 
the heavy and light chains), ~hc two polypcptidus need to bc assembled correctly, in order to result in a functional antibody. The studies on a catalytic 
antibody suggest that this is thccasc, and that IIW antibody runctions identically to the native murinc-derived antibody. Theonlydilkrcnccobservcd 
was in the glycosylation of the heavy chain, Further transgcnic plants arc being gencrated to product monoclonal antibodies that may be used 
therapeutically (and arc therefore required in large quantities). or to provide disease resistance iuplants. In addition. the ability of plants to assemble 
antibody complexes i being investigated further. to study the possibility of generating secretory IgA, which consists of heavy and light chains as 
well us two additional polypcptidc units. 
Monoclonal antibody; Transgenic plant; lmmunoglobulin heavy chain; lmmunoglobulin light chain; Immunoglobulin assembly; Passive immunisa- 
lion 
1. 1NTROD’;CTION 
A variety of bioactive compounds have been stably 
introduced into plants using genetic engineering tech- 
niques [l-12]. These compounds, by and large, are de- 
rived from mammalian, bacterial, or viral genes which 
encode well-characterized protein products. In some in- 
stances other bioactive plant products have been intro- 
duced into a new plant environment o obtain a useful 
trait. There are three characteristics of plant cells which 
make them valuable tools for the synthesis and analysis 
of bioactive compounds. Firstly, many plant cells can 
be propagated either as clumps of cells on agar plates 
(callus), as liquid suspension cultures, or as protoplasts 
from which the cell walls have been removed [13-14. 
Secondly, whole plants can he regenerated from callus 
cultures or from protoplasts [13,16]. Thirdly, sexual 
crossing of transgenic plants can be used to introduce 
additional genes into the progeny. Thus the genes re- 
quired for complex oligomeric ompounds can be accu- 
mulated by a series of crosses. 
signal sequences in the immunoglobulin genes and be- 
cause of specialized cellular machinery to accommodate 
these functions. However, it was not known whether 
plant cells could fulfill these requirements. 
The initial studies of antibodies in plant focussed on 
the IgG class of antibodies, although as discussed later, 
we are now also investigating the production of multi- 
mcric forms of immunoglobuiin. This paper will review 
the properties of antibodies produced in plants and dis- 
cuss the potential use of this technology for the produc- 
tion of forms of antibody which have not been possible 
by conventional techniques. 
2. PLANT TRANSFORMATlON AND ANTI- 
BODY SYNTHESIS 
Expression of monoclonal antibodies in plants is of 
particular interest, because it requires the expression of 
two genes, synthesis of two proteins and subsequently, 
the correct assembly of the tetrameric protein to result 
in functional antibody. The fidelity of such assembly is 
ensured in cells which normally synthesize immuno- 
globulins because of the recognition of processing and 
The most commonly used method for DNA mediated 
transformation of plants, is to employ Agrobuctrrium 
turtzefkicns as the ‘delivery vehicle’ for introduction of 
recombinant vectors to the plant cell nucleus [17-IS]. 
Not all plants are amenable to the manipulations re- 
quired for the stable introduction of foreign DNA. To- 
bacco is the most commonly used plant, since it is easily 
transformed and regenerated. However, a tremendous 
effort is being made in various laboratories to perfect 
transformation techniques for common crop planla 
such as corn, soybean, alfalfa and rice. 
Corre~~or~~e~tcc nddrws: A. Hiatt. Department of Cell Biology, The 
Scripps Research Institute, La Jolla, CA ‘XXX?, USA. 
As plant expression vectors are generally large al- 
ready [28], and contain only one promoter and one 
polylinker egion, it is probably wise to express only one 
immunoglobulin in each vector and to transform sepa- 
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rate plants with individual heavy and light chain-ex- 
pressing vectors. As described below, plants expressing 
functional antibodies are produced in the progeny of a 
cross pollination between the individual heavy or light 
chain containing plants. 
A murine IgGl antibody, that recognises a synthetic 
phosphonate ster and catalyses the hydrolysis of cer- 
tain carboxylic esters [20] has been studied. y and IC 
chain cDNAs were cloned individually into the plant 
expression vector pMGN 530 [21]. This vector contains 
plant selectable markers, promoters, E. coli and Agro- 
bacrerilttn origins of replication and a mouse immuno- 
globulin signal sequence upstream from the PCR insert. 
Transgenic plants were regenerated using these con- 
structs [22]. 
The levels of expression of y or K chain in trans- 
formed plants are shown in Table IA. Overall, y chain 
expression was higher than K chain expression. Trans- 
genie plants containing y or K chains were then crossed 
to produce progeny expressing both chains. The accu- 
mulation levels of y and K chains in the F, plants, 
yL@L) and rcL(yL) respectively, are also shown in 
Table IA. y and K chains were expressed in equivalent 
amounts - 3330 ng/mg and 3700 ng/mg, respectively, 
and at much higher levels compared with the previous 
generation of plants that only had one insert. 
The distribution of antibody chain gene expression i  
the F, progeny is shown in Table IB. In a cross between 
y and K chain plants, I l/18 of the offspring expressed 
y and K chains together. Furthermore, assembly was 
observed in the majority of these plants (95%). A pro- 
portion expressed only one chain and 4 plants expressed 
neither. That the F, plants contained assembled func- 
tional antibody, was determined by the following crite- 
ria: (1) Western blots of plant extracts; (2) ELISA as- 
Table 1 
Expression and assembly of immunoglobulin y and K chains in to- 
bacco 
A. Accumulation of y or K chains in transformed plants. Results are 
expressed as mean ?; S.D. nglmg total protein, estimated by ELBA 
assay. 
Y y (KY K K (Y)” 
1,412+270 3,330 -1- 2,000 56 k 5 3,700 k 2,300 
(2.400) (12,500) (80) (12,500) 
“Y(K) refers to y chains in a plant that also expresses K chains, and vice 
versa. Numben in parentheses are values for plants with the highest 
levels of accumulation. 
5. Distribution and assembly in crosses. Results are expressed as the 
number of plants expressing 7 or k chains among the progeny of a 
sexual cros5. 
7 only ti only YK null -. 
KXY 3 10 
(95 + 16?Passcmb!y) 
4 
72 
says in which antibody in plant extracts was captured 
with goat anti-mouse y chain and detected with HRPO 
labelled goat anti-mouse K chain; (3) ELISA assays 
using the native antigen in which the affinity of Y-K 
complexes for antigen was identical to that of the hy- 
bridoma-derived antibody. 
The functional activity of the plant-derived antibody 
was compared with that of the ascites derived antibody. 
Antigen specificity was confirmed by inhibition of bind- 
ing by free antigen, in which the half minimal inhibition 
was about 10 mM for both antibodies. The catalytic 
activities of both antibodies d.iffered by less than an 
order of magnitude for each parameter examined (Table 
11). These measurements are within the observed range 
for different batches of the ascites produced antibody 
(Janda, unpublished ata). 
A surprisingly high level of accumulation of func- 
tional antibody was observed amounting to greater than 
1% of total extractable protein. Other antibodies, which 
have subsequently been expressed in tobacco using the 
same strategy have resulted in similar levels of accumu- 
lation. 
3. CHARACTERlSTICS OF THE FC REGION 
Purified antibody was prepared using Sephacryl 
FPLC and Protein A-Sepharose. The quantitative re- 
tention on Protein A-Sepharose indicates that the re- 
gion between the CH2 and CH3 domains that is recog- 
nised by protein A was intact. 
Evidence that the antibody had been proteolytically 
processed in the lumen of the ER was provided by the 
N-terminal amino acid sequence. Heavy chain from ei- 
thcr plant antibody or mouse derived 6D4 was inlracta- 
ble to sequencing, indicating a blocked N terminus. The 
light chain N-terminal sequence was Asp-Val-Val-Leu 
for both plant and mouse antibody. This demonstrates 
appropriate proteolytic processing of the mouse signal 
sequence by the plant ER. 
Glycosylation of the antibody heavy chain was inves- 
tigated by lectin binding analysis [23,24]. Both plant and 
ascites y chain were bound by Concanavalin A (specific 
for mannose and glucose), but ascites y chain was also 
recognised by lectins from Ricinus cotmunis (specific 
for terminal golactose and N-acetylgalactosnmine) and 
wheat germ agglutinin (N-acetylglucosamine dimers, 
terminal sialic acid); [25]. This suggests adifferent com- 
Table II 
Cat;tly:ic activity of the GD4 antibody produced in tobacco 
source Tobacco Ascites 
I.41 x IO-h 
0.057 X !O-” 
0.47 X 10 ‘ 
(competitive) 
0.008 
9.8 x lOA 
0.31 X IO-” 
I.OG X IO” 
(compelilive) 
0.025 
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position of terminal residues on the plant glycan and is 
consistent with the absence of NANA in plants. The 
lectins from Duturr~ strcmoMm (N-acetyl glucosamine 
oligomers, N-acctyl sctosamine) and Pl~aseofus uutguris 
(galactose-/%,4-N-acctyl glucosamine-PI ,Z-mannose) 
did not bind to either plant or ascites-derived y chain. 
Both &cans were resistant o endoglycosidase H, 
which is a characteristic of complex carbohydrates 
processed in the Golgi apparatus and indicates that the 
transgenic antibody is processed in a similar fashion to 
complex mammalian glycoproteins. !n addition, both 
glycans have approximately the same affinity for Con 
A since they were not distinguishable by competition 
with a-methyl mannoside. This type of assay has previ- 
ously been used to distinguish a variety of plant glycans 
with respect o their affinity for lectin [26]. 
4. FURTHER STRATEGIES FOR EXPRESSION 
OF ANTlBODIES IN PLANTS 
Vectors encoding Ig heavy and light chains can be 
introduced into tobacco protoplasts by electroporation 
or by using polyethylene glycol as a facilitator [27]. 
Transient expression results in the synthesis, assembly 
and secretion of functional antibodies, This system is 
more rapid than plant transformation and regeneration 
ancl has been used to investigate a variety of vector 
constructs based on differences in the type and arrange- 
ment of promoters. 
In general, we found that different antibody struc- 
:!:rcc: c:en be I;;,&srcd G*am plant cells by a number of 
promoter arrangements in ‘iiie vector. Two types of con- 
structs were made to measure the effects of variations 
in levels of transcription on tll;f accumulation of se- 
creted antibody. In the first construct, the heavy or light 
chain expression cassette containing the 3% promoter, 
cDNA and 3’ nos region in pMON530 [21] were intro- 
duced into the vector pKYLX71 [29] at the HilzdIII site. 
This resulted in a vector with two 3% promoters up- 
stream from the cDNA. The expression of secreted an- 
tibody from protoplasts electroporated with these vec- 
tors was at least IO-fold more efficient han constructs 
employing a single 3% promoter. 
In a second construct, the 35s promoter was substi- 
tuted by the HSP 70 heat-shock inducible promoter 
from soybean [38]. Although heat-shock induction of 
antibody production was not achieved in protoplasts, 
plants that were regenerated after leaf-disc transforma- 
tion using the same vectors, expressed y and K chains 
only after exposure to 37” C for one hour. Some of the 
progeny from a cross between y and K expressing plants 
expressed functional antibody, but only if both parent 
plants had been transformed with the HSF 70 construct. 
No antibody was expressed if one parental plant con- 
tained the 3% promoter and the other expressed the 
HSP 70 promoter. 
The results from analysis of regenerated plants ex- 
pressing heavy and light chain constructs uggested that 
the native signal sequence on the mouse transcript con- 
tributes significantly to the accumulation of heavy or 
light chains [22]. We have also found that virtually any 
signal sequence can be employed, including other mouse 
signal pptides as well as pro-sequences derived from 
microorganisms. cDNAs with no signal sequence have 
also been introduced into protoplasts by electropora- 
tion [30,31]. Expression of individual chains was barely 
detectible and when both chains were co-expressed, 
there was no assembly of y-h: complexes. This effect is 
presumably due to the sequestering of the chains in the 
endomembrane system and their subsequent secretion 
when leader sequences are present. Our results uggest 
that plants must contain an assembly and processing 
apparatus which can recognize mouse immunoglob- 
ulins. The efficiency of assembly in plants was surpris- 
ing since there was a large disparity in parental evels 
of expression of indidivual y or K chains. After crossing, 
one of the antibody producing progeny contained 5-fold 
more y and 160-fold more K chain than the respective 
parental plants. This suggests that the assembled anti- 
body is more stable in plants than the individual heavy 
or light chains. It is apparent hat cognate mechanisms 
function in plants to coordinate the assembly of oligom- 
ers, to direct N-glycosylation and to effect processing in 
the Golgi apparatus, to recognize and to process immu- 
noglobulins efficiently. In mammalian cells, assembly of 
immunoglobulin chains is thought to occtir via a native 
component of the endoplasmic reticulum (BiP), which 
is involved in the post-translational processing of heavy 
chains [32] and a BiP-like protein has recently been 
characterized in plants [33,34]. 
In order to express both y and rc chains in the initial 
transformant, promoter arrangements whereby  and K 
cDNAs are encoded in the same vector have been 
tested. A vector, pHi202 [22; was used which contains 
the leader and y chain insert. In addition, a Mi!rdIII 
fragment containing an additional 3% promoter [2i]. 
the light chain cDN+, and the nopaiine synthase gene 
3’cnd were introduced. The two orientations of the dou- 
ble expression vector were then introduced into pro- 
toplasts. Only the ‘head-to-tail’ orientation resulted in 
expression of assembled antibody. The efficiency of ex- 
pression (as measured by the ng of antibody produced 
from 10’ cells electroporatcd with 20 mg DNA) was 
significantly higher than clectroporation using two vec- 
tors. 
Most of the characterisation of antibodies from 
plants performed to date, has been on antibodies which 
have been targeted for secretion through the plasma 
membrane [22]. Alternative techniques for the efficient 
production of intracellular antibodies have yet to be 
tested, One possibility is the single chain antibody con- 
struct [35-371 in which endomcmbrane associated as- 
sembly of heavy and light chains is replaced by refolding 
73 
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of variable regions joined by a peptide linker. This obvi- 
ously requires aconsiderable amount of molecular engi- 
neering, but if successful, offers a realistic approach to 
introducing antigen binding to the plant cytosol or 
other compartments. 
5. APPLICATIONS OF PLANT DERIVED MONO- 
CLONAL ANTIBODIES 
Although transformation of plants is a lengthy proc- 
ess, there are several advantages over other expression 
systems. The prospect of harvesting muliuclonal anti- 
body on an agricultural scale would mean that antibod- 
ies would be available xtremely cheaply in almost lim- 
itless amounts. One of the most attractive potential uses 
for large quantities of antibody is in passive immunisa- 
tion. Monoclonal antibodies have been used in vivo for 
many human diseases with varying degrees of success 
and recently we have been interested in the possibility 
of orally delivered MAb. If the rigbt transgenic plants 
were used, the antibody might be administered irectly, 
without the need for extraction or purification. Topi- 
cally applied MAb has been used successfully to prevent 
oral disease in both sub-human primates [38] and hu- 
mans [39]. Transgenic plants that produce the MAb 
Guy’s 13 that was used in the human studies, are cur- 
rently being constructed. 
Transgenic plants offer a number of advantages with 
respect o vaccine storage and distribution. Plant ge- 
netic material is readily stored in seeds, which are ex- 
tremely stable and require little or no maintenance. Un- 
like the considerably more stringent requirements of 
bacterial or mammalian cells, seeds have an almost un- 
limited shelf life in ambient conditions. Immortalisation 
of the plant line therefore is extremely simple, further- 
more, mature plants can be self fertilised to produce 
identical offspring, a technique that has been estab- 
lished in plant breeding programmes for many years. As 
the number of transformable plant species increases, to 
include several of the major food crops such as rice, 
potato, cassava nd peppers, the possibility arises of 
delivering antibody vaccines on a global scale, using 
plants that are indigenous to particular egions. In this 
way, vaccines could be administered cheaply to third 
world countries by utilising the existing ag&Lltural in- 
frastructure. 
joined by a small polypeptide (J chain), and complexed 
with a larger polypeptide (the secretory component) 
[40]. Although J chain is synthesised by the plasma cells 
that secrete the IgA, secretory component is expressed 
by epithelial cells that are present in the secretory 
glands. Because of this, it has not been possible to gen- 
erate monoclonal sIgA using standard hybridoma tech- 
niques. However, the genes that encode the four compo- 
nent chains of sIgA could be incorporated into one 
plant by cross breeding, although it remains to be deter- 
mined whether correct assembly of antibody woud 
occur. 
As the majority of infectious agents are initially en- 
countered at mucosal sites of the body, topical passive 
immunisation with slgA may be an effective measure 
against many diseases. This approach would overcome 
the difficulties previously encountered with regard to 
inducing high and long lasting titres of specific antibody 
[4l], as well as avoidi,lg the possibility of developing 
oral tolerance. 
Other multimeric antibody molecules could also be 
constructed in plants. Thus, the product of two trans- 
genie plants, each producing different antibodies, would 
be a bifunctional antibody and in theory, any combina- 
tion of heavy and light chains could be made. In addi- 
tion, we are alsc investigating the possibility of engi- 
neering a secretory form of IgO, which would be multi- 
valent and might be more stable in the mucosal environ- 
ment, yet still retain the functions of the IgG Fc region. 
Antibodies have previously always been considered 
as part of mammalian defence systems. The possibility 
now arises of utilising pathogen-specific antibodies to 
provide disease resistance in plants. The effector mech- 
anisms in plants m::y be limited to agglutination, en- 
zyme inhibition and blocking of essential antigenic epi- 
topes. However, it may also be possible to engineer 
antibodies that could take advantage of plant mecha- 
nisms for disease resistance. For example, plant toxins 
could be targetted to invading organisms by conjuga- 
tion with specilic antibody. Alternatively, genes for pes- 
ticides, such as the S-endotoxin of Bucilfus thrir~giensis, 
could be engineered within those encoding the antibody, 
in order to target hese pesticides to the plant pathogen. 
6. SUMMARY 
In addition to the economic advantages ofusing plant 
derived antibodies, the ease with which genetic material 
can be exchanged by cross fertiiisation, may facilitate 
the construction of multimeric forms of antibody. The 
ability of plant cells to assembly heavy and light anti- 
body chains correctly, has been demonstrated [22]. The 
possibility of constructing antibodies that require more 
than two polypeptide chains is being explored, and the 
secretory form of IgA (sIgA.) is of particular interest. 
sIgA is usually present at mucous membranes as a 
dimer, consisting of two monomeric IgA molecules 
Of the variety of compounds expressed in transgenic 
plants, antibodies probably offer the widest range of 
applications. The antibodies appear to possess all of the 
functional characteristics of tbose derived from hybrid- 
oma cells, ;Ilthough further study will be required to 
determine the effect of the difference in heavy chain 
glycosylation. More work will also be directed toward 
the assembly, accumulation, stability and secretion of 
plant antibodies. Methods for achieving high level ex- 
pression of foreign gene products consistently in the 
new plant environment have not been established yet. 
74 
Volume 307, number I FEBS LETTERS July 1992 
However, there is a range of options potentially availa- 
ble and temporally controlled {deve!opmental or induci- 
ble), tissue-specific, f ce!l-r-pecific expression of the gene 
may lead to the desired result. In the case of tobacco, 
the accumulation of antibodies throughout the plant 
accounted for more than 1% of the total extractable 
protein. Conceivably, with some manipulation of the 
transcription rates, the accumulation of an antibody 
either in whole plants or in specific tissues, could be 
increased significantly further. 
Plant antibody technology is still in its infancy. How- 
ever, it offers enormous potential in ‘mix-and-match’ 
antibody engineering, and the construction of multi- 
merit immunoglobulin complexes may be feasible rela- 
tively easily, for the first time. Furthermore, as there is 
an enduring interest in using antibodies for therapeutic 
purposes, agricultural production and distribution of- 
fers a means of obtaining large quantities of antibodies 
ae a relatively low cost. 
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